nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—SLC22A8—choroid plexus—malignant glioma	0.173	0.321	CbGeAlD
Cefazolin—PON1—blood vessel—malignant glioma	0.138	0.256	CbGeAlD
Cefazolin—PON1—central nervous system—malignant glioma	0.0381	0.0707	CbGeAlD
Cefazolin—PON1—brain—malignant glioma	0.0303	0.0561	CbGeAlD
Cefazolin—TPMT—retina—malignant glioma	0.0222	0.0411	CbGeAlD
Cefazolin—TPMT—telencephalon—malignant glioma	0.0204	0.0378	CbGeAlD
Cefazolin—Nephropathy toxic—Carmustine—malignant glioma	0.0199	0.0491	CcSEcCtD
Cefazolin—Oral candidiasis—Carmustine—malignant glioma	0.018	0.0444	CcSEcCtD
Cefazolin—Oral candidiasis—Temozolomide—malignant glioma	0.0174	0.0429	CcSEcCtD
Cefazolin—TPMT—medulla oblongata—malignant glioma	0.016	0.0297	CbGeAlD
Cefazolin—TPMT—midbrain—malignant glioma	0.0147	0.0272	CbGeAlD
Cefazolin—Cholestasis—Temozolomide—malignant glioma	0.0146	0.0359	CcSEcCtD
Cefazolin—TPMT—spinal cord—malignant glioma	0.0143	0.0265	CbGeAlD
Cefazolin—TPMT—central nervous system—malignant glioma	0.0116	0.0215	CbGeAlD
Cefazolin—TPMT—cerebellum—malignant glioma	0.0113	0.021	CbGeAlD
Cefazolin—Vaginal inflammation—Temozolomide—malignant glioma	0.0111	0.0272	CcSEcCtD
Cefazolin—Candida infection—Carmustine—malignant glioma	0.0109	0.0269	CcSEcCtD
Cefazolin—Candida infection—Temozolomide—malignant glioma	0.0106	0.026	CcSEcCtD
Cefazolin—Vaginal infection—Temozolomide—malignant glioma	0.0104	0.0257	CcSEcCtD
Cefazolin—Aplastic anaemia—Temozolomide—malignant glioma	0.0104	0.0256	CcSEcCtD
Cefazolin—Phlebitis—Carmustine—malignant glioma	0.00964	0.0237	CcSEcCtD
Cefazolin—TPMT—brain—malignant glioma	0.00921	0.0171	CbGeAlD
Cefazolin—SLC22A6—brain—malignant glioma	0.00917	0.017	CbGeAlD
Cefazolin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00723	0.0178	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00723	0.0178	CcSEcCtD
Cefazolin—ABCC4—central nervous system—malignant glioma	0.00697	0.0129	CbGeAlD
Cefazolin—SLC22A8—central nervous system—malignant glioma	0.00692	0.0128	CbGeAlD
Cefazolin—Pancytopenia—Carmustine—malignant glioma	0.00682	0.0168	CcSEcCtD
Cefazolin—Neutropenia—Carmustine—malignant glioma	0.00671	0.0165	CcSEcCtD
Cefazolin—Pancytopenia—Temozolomide—malignant glioma	0.00659	0.0162	CcSEcCtD
Cefazolin—Neutropenia—Temozolomide—malignant glioma	0.00649	0.016	CcSEcCtD
Cefazolin—Renal failure—Carmustine—malignant glioma	0.00629	0.0155	CcSEcCtD
Cefazolin—Stomatitis—Carmustine—malignant glioma	0.00624	0.0154	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00613	0.0151	CcSEcCtD
Cefazolin—Stomatitis—Temozolomide—malignant glioma	0.00603	0.0148	CcSEcCtD
Cefazolin—Haemoglobin—Carmustine—malignant glioma	0.00577	0.0142	CcSEcCtD
Cefazolin—Haemorrhage—Carmustine—malignant glioma	0.00575	0.0141	CcSEcCtD
Cefazolin—ALB—brain—malignant glioma	0.00572	0.0106	CbGeAlD
Cefazolin—Haemoglobin—Temozolomide—malignant glioma	0.00558	0.0137	CcSEcCtD
Cefazolin—Haemorrhage—Temozolomide—malignant glioma	0.00555	0.0137	CcSEcCtD
Cefazolin—Hepatitis—Temozolomide—malignant glioma	0.00555	0.0137	CcSEcCtD
Cefazolin—ABCC4—brain—malignant glioma	0.00554	0.0103	CbGeAlD
Cefazolin—SLC22A8—brain—malignant glioma	0.00549	0.0102	CbGeAlD
Cefazolin—Erythema multiforme—Temozolomide—malignant glioma	0.00525	0.0129	CcSEcCtD
Cefazolin—Anaemia—Carmustine—malignant glioma	0.00462	0.0114	CcSEcCtD
Cefazolin—Agitation—Carmustine—malignant glioma	0.0046	0.0113	CcSEcCtD
Cefazolin—Leukopenia—Carmustine—malignant glioma	0.00448	0.011	CcSEcCtD
Cefazolin—Anaemia—Temozolomide—malignant glioma	0.00447	0.011	CcSEcCtD
Cefazolin—Agitation—Temozolomide—malignant glioma	0.00444	0.0109	CcSEcCtD
Cefazolin—Convulsion—Carmustine—malignant glioma	0.00433	0.0107	CcSEcCtD
Cefazolin—Leukopenia—Temozolomide—malignant glioma	0.00433	0.0107	CcSEcCtD
Cefazolin—Convulsion—Temozolomide—malignant glioma	0.00419	0.0103	CcSEcCtD
Cefazolin—Confusional state—Carmustine—malignant glioma	0.00412	0.0101	CcSEcCtD
Cefazolin—Thrombocytopenia—Carmustine—malignant glioma	0.004	0.00984	CcSEcCtD
Cefazolin—Confusional state—Temozolomide—malignant glioma	0.00398	0.00979	CcSEcCtD
Cefazolin—Anaphylactic shock—Temozolomide—malignant glioma	0.00394	0.00971	CcSEcCtD
Cefazolin—Anorexia—Carmustine—malignant glioma	0.00389	0.00958	CcSEcCtD
Cefazolin—Thrombocytopenia—Temozolomide—malignant glioma	0.00386	0.00951	CcSEcCtD
Cefazolin—Hypotension—Carmustine—malignant glioma	0.00381	0.00939	CcSEcCtD
Cefazolin—Anorexia—Temozolomide—malignant glioma	0.00376	0.00926	CcSEcCtD
Cefazolin—Somnolence—Carmustine—malignant glioma	0.00363	0.00894	CcSEcCtD
Cefazolin—Decreased appetite—Carmustine—malignant glioma	0.00355	0.00874	CcSEcCtD
Cefazolin—Somnolence—Temozolomide—malignant glioma	0.00351	0.00864	CcSEcCtD
Cefazolin—Pain—Carmustine—malignant glioma	0.00349	0.0086	CcSEcCtD
Cefazolin—Dyspepsia—Temozolomide—malignant glioma	0.00347	0.00855	CcSEcCtD
Cefazolin—Decreased appetite—Temozolomide—malignant glioma	0.00343	0.00844	CcSEcCtD
Cefazolin—Fatigue—Temozolomide—malignant glioma	0.0034	0.00838	CcSEcCtD
Cefazolin—Pain—Temozolomide—malignant glioma	0.00337	0.00831	CcSEcCtD
Cefazolin—Feeling abnormal—Carmustine—malignant glioma	0.00336	0.00828	CcSEcCtD
Cefazolin—Gastrointestinal pain—Carmustine—malignant glioma	0.00334	0.00822	CcSEcCtD
Cefazolin—Feeling abnormal—Temozolomide—malignant glioma	0.00325	0.00801	CcSEcCtD
Cefazolin—Body temperature increased—Carmustine—malignant glioma	0.00323	0.00795	CcSEcCtD
Cefazolin—Abdominal pain—Carmustine—malignant glioma	0.00323	0.00795	CcSEcCtD
Cefazolin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00323	0.00794	CcSEcCtD
Cefazolin—Urticaria—Temozolomide—malignant glioma	0.00313	0.00772	CcSEcCtD
Cefazolin—Abdominal pain—Temozolomide—malignant glioma	0.00312	0.00768	CcSEcCtD
Cefazolin—Body temperature increased—Temozolomide—malignant glioma	0.00312	0.00768	CcSEcCtD
Cefazolin—Hypersensitivity—Carmustine—malignant glioma	0.00301	0.00741	CcSEcCtD
Cefazolin—Asthenia—Carmustine—malignant glioma	0.00293	0.00721	CcSEcCtD
Cefazolin—Hypersensitivity—Temozolomide—malignant glioma	0.00291	0.00716	CcSEcCtD
Cefazolin—Asthenia—Temozolomide—malignant glioma	0.00283	0.00697	CcSEcCtD
Cefazolin—Diarrhoea—Carmustine—malignant glioma	0.00279	0.00688	CcSEcCtD
Cefazolin—Pruritus—Temozolomide—malignant glioma	0.00279	0.00687	CcSEcCtD
Cefazolin—Dizziness—Carmustine—malignant glioma	0.0027	0.00665	CcSEcCtD
Cefazolin—Diarrhoea—Temozolomide—malignant glioma	0.0027	0.00665	CcSEcCtD
Cefazolin—Dizziness—Temozolomide—malignant glioma	0.00261	0.00642	CcSEcCtD
Cefazolin—Vomiting—Carmustine—malignant glioma	0.0026	0.00639	CcSEcCtD
Cefazolin—Rash—Carmustine—malignant glioma	0.00257	0.00634	CcSEcCtD
Cefazolin—Dermatitis—Carmustine—malignant glioma	0.00257	0.00633	CcSEcCtD
Cefazolin—Headache—Carmustine—malignant glioma	0.00256	0.0063	CcSEcCtD
Cefazolin—Vomiting—Temozolomide—malignant glioma	0.00251	0.00618	CcSEcCtD
Cefazolin—Rash—Temozolomide—malignant glioma	0.00249	0.00612	CcSEcCtD
Cefazolin—Dermatitis—Temozolomide—malignant glioma	0.00248	0.00612	CcSEcCtD
Cefazolin—Headache—Temozolomide—malignant glioma	0.00247	0.00609	CcSEcCtD
Cefazolin—Nausea—Carmustine—malignant glioma	0.00242	0.00597	CcSEcCtD
Cefazolin—Nausea—Temozolomide—malignant glioma	0.00234	0.00577	CcSEcCtD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.000456	0.00836	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—malignant glioma	0.000451	0.00827	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000425	0.00779	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000414	0.00759	CbGpPWpGaD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.000408	0.00747	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000389	0.00712	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—PDGFB—malignant glioma	0.000365	0.0067	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—COX8A—malignant glioma	0.000361	0.00662	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—SLC5A5—malignant glioma	0.000355	0.0065	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.000348	0.00638	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00034	0.00623	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—SLC6A3—malignant glioma	0.000338	0.00619	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—APOD—malignant glioma	0.00033	0.00606	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—FN1—malignant glioma	0.00033	0.00604	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000324	0.00594	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.000314	0.00575	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—EGF—malignant glioma	0.000312	0.00571	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000311	0.00569	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ASMT—malignant glioma	0.000307	0.00563	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—SOD1—malignant glioma	0.000307	0.00563	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000306	0.0056	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.000297	0.00544	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000296	0.00543	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000291	0.00533	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—TP53—malignant glioma	0.000289	0.0053	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—BCAN—malignant glioma	0.000289	0.0053	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ATP1B2—malignant glioma	0.000287	0.00526	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—GSTP1—malignant glioma	0.000286	0.00524	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000284	0.00521	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00027	0.00496	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PTGS1—malignant glioma	0.000262	0.0048	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000259	0.00475	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—APOD—malignant glioma	0.000252	0.00462	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—SOD1—malignant glioma	0.00025	0.00458	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000248	0.00455	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000247	0.00453	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—APOD—malignant glioma	0.000242	0.00443	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.000241	0.00441	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—CAT—malignant glioma	0.000237	0.00435	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000233	0.00427	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—IDH2—malignant glioma	0.000233	0.00427	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—KNG1—malignant glioma	0.000231	0.00423	CbGpPWpGaD
Cefazolin—ALB—Lipid and lipoprotein metabolism—CAV1—malignant glioma	0.000228	0.00418	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000226	0.00415	CbGpPWpGaD
Cefazolin—ABCC4—NRF2 pathway—PDGFB—malignant glioma	0.000226	0.00414	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000222	0.00407	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—malignant glioma	0.00022	0.00403	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2B6—malignant glioma	0.000219	0.00401	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000216	0.00396	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000215	0.00394	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—SOD1—malignant glioma	0.000214	0.00393	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—DOCK6—malignant glioma	0.000214	0.00393	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—F2—malignant glioma	0.000214	0.00392	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ANGPT2—malignant glioma	0.000212	0.00388	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—APOD—malignant glioma	0.00021	0.00385	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.00021	0.00385	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—malignant glioma	0.000204	0.00374	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—IDH1—malignant glioma	0.0002	0.00367	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—SOD1—malignant glioma	0.000199	0.00364	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000195	0.00357	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SPHK1—malignant glioma	0.000194	0.00355	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000193	0.00354	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CYP2C18—malignant glioma	0.00019	0.00348	CbGpPWpGaD
Cefazolin—ABCC4—Platelet degranulation—VEGFA—malignant glioma	0.000189	0.00346	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—CAT—malignant glioma	0.000189	0.00346	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000185	0.00339	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HIST1H3B—malignant glioma	0.000183	0.00336	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—MYB—malignant glioma	0.000181	0.00333	CbGpPWpGaD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.00018	0.00329	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—F2—malignant glioma	0.000174	0.00319	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000169	0.0031	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—PDGFB—malignant glioma	0.000165	0.00303	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000162	0.00297	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IFNG—malignant glioma	0.000162	0.00297	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.000158	0.00289	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000155	0.00285	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTT1—malignant glioma	0.000154	0.00281	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—FN1—malignant glioma	0.000149	0.00273	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000148	0.00271	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000146	0.00268	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000146	0.00268	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—IL1B—malignant glioma	0.000145	0.00265	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS1—malignant glioma	0.000144	0.00264	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.000142	0.0026	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—H3F3A—malignant glioma	0.000141	0.00259	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—EGF—malignant glioma	0.000141	0.00259	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000141	0.00258	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.00014	0.00256	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000138	0.00253	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—F2—malignant glioma	0.000138	0.00253	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.000134	0.00246	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—BCHE—malignant glioma	0.000134	0.00245	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SLC5A5—malignant glioma	0.000132	0.00242	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IFNG—malignant glioma	0.000132	0.00242	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ATP1B2—malignant glioma	0.00013	0.00238	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000129	0.00236	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000129	0.00236	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000128	0.00235	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000124	0.00227	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000123	0.00225	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000118	0.00217	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL1B—malignant glioma	0.000118	0.00216	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL2—malignant glioma	0.000117	0.00215	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KNG1—malignant glioma	0.000117	0.00214	CbGpPWpGaD
Cefazolin—ALB—Metabolism—RTEL1—malignant glioma	0.000115	0.0021	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IFNA2—malignant glioma	0.000114	0.00209	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000114	0.00208	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000113	0.00207	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000112	0.00206	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—malignant glioma	0.000112	0.00206	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.00011	0.00201	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—APOD—malignant glioma	0.000109	0.002	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SOD1—malignant glioma	0.000108	0.00198	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000108	0.00198	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000108	0.00197	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000107	0.00196	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—GSTP1—malignant glioma	0.000106	0.00195	CbGpPWpGaD
Cefazolin—ALB—Vitamin B12 Metabolism—TNF—malignant glioma	0.000105	0.00192	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IFNG—malignant glioma	0.000105	0.00192	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CAT—malignant glioma	0.000104	0.0019	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000102	0.00188	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000101	0.00185	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	0.0001	0.00184	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PTK2—malignant glioma	9.94e-05	0.00182	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.89e-05	0.00181	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—IL2—malignant glioma	9.85e-05	0.0018	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NCOR1—malignant glioma	9.78e-05	0.00179	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	9.63e-05	0.00176	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—ANGPT2—malignant glioma	9.57e-05	0.00175	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	9.51e-05	0.00174	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.41e-05	0.00172	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	9.34e-05	0.00171	CbGpPWpGaD
Cefazolin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	8.79e-05	0.00161	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	8.73e-05	0.0016	CbGpPWpGaD
Cefazolin—ALB—Platelet degranulation—VEGFA—malignant glioma	8.54e-05	0.00156	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TNF—malignant glioma	8.53e-05	0.00156	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	8.37e-05	0.00153	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PDGFB—malignant glioma	8.36e-05	0.00153	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HIST1H3B—malignant glioma	8.29e-05	0.00152	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—MYB—malignant glioma	8.21e-05	0.00151	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.19e-05	0.0015	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	8.13e-05	0.00149	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CAV1—malignant glioma	7.97e-05	0.00146	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.93e-05	0.00145	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CAV1—malignant glioma	7.92e-05	0.00145	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—F2—malignant glioma	7.54e-05	0.00138	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—FN1—malignant glioma	7.54e-05	0.00138	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—malignant glioma	7.52e-05	0.00138	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	7.34e-05	0.00134	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CG—malignant glioma	7.26e-05	0.00133	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—malignant glioma	7.21e-05	0.00132	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—EGF—malignant glioma	7.13e-05	0.00131	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PTPN11—malignant glioma	7.09e-05	0.0013	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARG—malignant glioma	7.01e-05	0.00128	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—malignant glioma	6.78e-05	0.00124	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—RAF1—malignant glioma	6.7e-05	0.00123	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	6.62e-05	0.00121	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	6.62e-05	0.00121	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT2—malignant glioma	6.6e-05	0.00121	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COX8A—malignant glioma	6.59e-05	0.00121	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	6.54e-05	0.0012	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—H3F3A—malignant glioma	6.4e-05	0.00117	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—malignant glioma	6.39e-05	0.00117	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—malignant glioma	6.34e-05	0.00116	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	6.33e-05	0.00116	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	6.26e-05	0.00115	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.89e-05	0.00108	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	5.79e-05	0.00106	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RAF1—malignant glioma	5.66e-05	0.00104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ASMT—malignant glioma	5.6e-05	0.00103	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	5.6e-05	0.00103	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	5.57e-05	0.00102	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—malignant glioma	5.57e-05	0.00102	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—malignant glioma	5.53e-05	0.00101	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—malignant glioma	5.51e-05	0.00101	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.47e-05	0.001	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—malignant glioma	5.34e-05	0.000978	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KNG1—malignant glioma	5.28e-05	0.000967	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BCAN—malignant glioma	5.26e-05	0.000965	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IFNA2—malignant glioma	5.17e-05	0.000947	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.14e-05	0.000942	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—RAF1—malignant glioma	5.11e-05	0.000937	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IL2—malignant glioma	5.08e-05	0.00093	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	4.97e-05	0.000911	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SOD1—malignant glioma	4.9e-05	0.000898	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—RAF1—malignant glioma	4.9e-05	0.000898	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.89e-05	0.000897	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	4.85e-05	0.000889	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTEN—malignant glioma	4.81e-05	0.000881	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PTK2—malignant glioma	4.5e-05	0.000825	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	4.46e-05	0.000817	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—VEGFA—malignant glioma	4.31e-05	0.00079	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	4.27e-05	0.000782	CbGpPWpGaD
Cefazolin—ALB—Metabolism—IDH2—malignant glioma	4.24e-05	0.000778	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4e-05	0.000733	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2B6—malignant glioma	3.99e-05	0.000731	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	3.79e-05	0.000694	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PDGFB—malignant glioma	3.78e-05	0.000693	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—KRAS—malignant glioma	3.67e-05	0.000672	CbGpPWpGaD
Cefazolin—ALB—Metabolism—IDH1—malignant glioma	3.65e-05	0.000669	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CAV1—malignant glioma	3.58e-05	0.000657	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SPHK1—malignant glioma	3.53e-05	0.000647	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2C18—malignant glioma	3.46e-05	0.000634	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—F2—malignant glioma	3.41e-05	0.000625	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—FN1—malignant glioma	3.41e-05	0.000625	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—malignant glioma	3.39e-05	0.000622	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—malignant glioma	3.37e-05	0.000617	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—malignant glioma	3.26e-05	0.000598	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.26e-05	0.000598	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—malignant glioma	3.26e-05	0.000597	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—EGF—malignant glioma	3.23e-05	0.000591	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PTPN11—malignant glioma	3.21e-05	0.000588	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT2—malignant glioma	2.99e-05	0.000547	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.97e-05	0.000544	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	2.96e-05	0.000542	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—malignant glioma	2.87e-05	0.000526	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.87e-05	0.000526	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTT1—malignant glioma	2.8e-05	0.000513	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—malignant glioma	2.77e-05	0.000508	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—malignant glioma	2.75e-05	0.000504	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS1—malignant glioma	2.62e-05	0.00048	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.61e-05	0.000479	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RAF1—malignant glioma	2.56e-05	0.000469	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—malignant glioma	2.5e-05	0.000458	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BCHE—malignant glioma	2.44e-05	0.000447	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	2.42e-05	0.000443	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC5A5—malignant glioma	2.41e-05	0.000441	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IL2—malignant glioma	2.3e-05	0.000421	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.28e-05	0.000417	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.26e-05	0.000413	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	2.22e-05	0.000406	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.97e-05	0.000361	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—VEGFA—malignant glioma	1.95e-05	0.000358	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GSTP1—malignant glioma	1.94e-05	0.000355	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAT—malignant glioma	1.89e-05	0.000346	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOR1—malignant glioma	1.78e-05	0.000327	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—KRAS—malignant glioma	1.66e-05	0.000304	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—malignant glioma	1.52e-05	0.000279	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—malignant glioma	1.47e-05	0.00027	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAV1—malignant glioma	1.45e-05	0.000266	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.39e-05	0.000254	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—malignant glioma	1.32e-05	0.000242	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARG—malignant glioma	1.28e-05	0.000234	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—malignant glioma	1.25e-05	0.000228	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—malignant glioma	1.16e-05	0.000213	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—malignant glioma	1.01e-05	0.000186	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—malignant glioma	1e-05	0.000184	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTEN—malignant glioma	8.76e-06	0.000161	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—malignant glioma	6.18e-06	0.000113	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—malignant glioma	5.05e-06	9.25e-05	CbGpPWpGaD
